Jun 24 |
Palisade Bio to Participate in the Virtual Investor Closing Bell Series
|
Jun 21 |
Palisade Bio Provides Update on Advancement of its Strategic Collaboration with Strand Life Sciences
|
Jun 11 |
Palisade Bio gets notice of allowance for Canadian patent covering lead product candidate
|
Jun 11 |
Palisade Bio Announces Notice of Allowance for Canadian Patent Covering Lead Product Candidate, PALI-2108
|
Jun 10 |
Palisade Bio to Present at the Virtual Investor Pitch Conference
|
May 21 |
Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse Models
|